Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older

ClinicalTrials.gov ID: NCT02514174

Public ClinicalTrials.gov record NCT02514174. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 9:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Single Arm Phase IV Study of Afatinib in Elderly Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Whose Tumors Have Epidermal Growth Factor Receptor (EGFR) Exon 19 Deletions or Exon 21(L858R) Substitution Mutations

Study identification

NCT ID
NCT02514174
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
25 participants

Conditions and interventions

Interventions

  • Afatinib Drug

Drug

Eligibility (public fields only)

Age range
70 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 17, 2015
Primary completion
Mar 27, 2019
Completion
Apr 24, 2019
Last update posted
Mar 29, 2020

2015 – 2019

United States locations

U.S. sites
10
U.S. states
7
U.S. cities
10
Facility City State ZIP Site status
Mayo Clinic-Arizona Scottsdale Arizona 85250
Pacific Cancer Medical Center, Inc. Anaheim California 92801
City of Hope Duarte California 91010
Compassionate Care Research Group, Inc. at Compassionate Cancer Care Medical Group, Inc. Fountain Valley California 92708
Los Angeles Hematology Oncology Medical Group Los Angeles California 90017
University of Miami Miami Florida 33136
Ingalls Memorial Hospital Harvey Illinois 60426
Baystate Health D'Amour Center for Cancer Care Springfield Massachusetts 01199
Montefiore Medical Center The Bronx New York 10467
Lankenau Medical Center Wynnewood Pennsylvania 19096

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02514174, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 29, 2020 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02514174 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →